UnitedHealth Group (UNH) Competitors $305.26 -2.16 (-0.70%) Closing price 08/25/2025 03:59 PM EasternExtended Trading$304.01 -1.25 (-0.41%) As of 08/25/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UNH vs. ALKS, MEDP, CI, CNC, CVS, ELV, HCA, HUM, JNJ, and MOHShould you be buying UnitedHealth Group stock or one of its competitors? The main competitors of UnitedHealth Group include Alkermes (ALKS), Medpace (MEDP), Cigna Group (CI), Centene (CNC), CVS Health (CVS), Elevance Health (ELV), HCA Healthcare (HCA), Humana (HUM), Johnson & Johnson (JNJ), and Molina Healthcare (MOH). These companies are all part of the "medical" sector. UnitedHealth Group vs. Its Competitors Alkermes Medpace Cigna Group Centene CVS Health Elevance Health HCA Healthcare Humana Johnson & Johnson Molina Healthcare Alkermes (NASDAQ:ALKS) and UnitedHealth Group (NYSE:UNH) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership, media sentiment and profitability. Do analysts rate ALKS or UNH? Alkermes presently has a consensus price target of $41.08, suggesting a potential upside of 41.67%. UnitedHealth Group has a consensus price target of $365.38, suggesting a potential upside of 19.69%. Given Alkermes' stronger consensus rating and higher possible upside, analysts plainly believe Alkermes is more favorable than UnitedHealth Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alkermes 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83UnitedHealth Group 3 Sell rating(s) 6 Hold rating(s) 15 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor ALKS or UNH? In the previous week, UnitedHealth Group had 102 more articles in the media than Alkermes. MarketBeat recorded 126 mentions for UnitedHealth Group and 24 mentions for Alkermes. UnitedHealth Group's average media sentiment score of 0.97 beat Alkermes' score of 0.57 indicating that UnitedHealth Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alkermes 9 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive UnitedHealth Group 80 Very Positive mention(s) 22 Positive mention(s) 15 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Positive Which has higher valuation & earnings, ALKS or UNH? UnitedHealth Group has higher revenue and earnings than Alkermes. UnitedHealth Group is trading at a lower price-to-earnings ratio than Alkermes, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlkermes$1.56B3.07$367.07M$2.0813.94UnitedHealth Group$400.28B0.69$14.41B$23.0813.23 Which has more volatility & risk, ALKS or UNH? Alkermes has a beta of 0.47, indicating that its stock price is 53% less volatile than the S&P 500. Comparatively, UnitedHealth Group has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500. Is ALKS or UNH more profitable? Alkermes has a net margin of 23.15% compared to UnitedHealth Group's net margin of 5.04%. Alkermes' return on equity of 24.86% beat UnitedHealth Group's return on equity.Company Net Margins Return on Equity Return on Assets Alkermes23.15% 24.86% 17.14% UnitedHealth Group 5.04%23.32%7.66% Do institutionals and insiders hold more shares of ALKS or UNH? 95.2% of Alkermes shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 4.4% of Alkermes shares are held by insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryAlkermes beats UnitedHealth Group on 11 of the 17 factors compared between the two stocks. Get UnitedHealth Group News Delivered to You Automatically Sign up to receive the latest news and ratings for UNH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UNH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UNH vs. The Competition Export to ExcelMetricUnitedHealth GroupMED IndustryMedical SectorNYSE ExchangeMarket Cap$278.42B$42.14B$5.81B$21.29BDividend Yield2.88%93.53%4.40%3.54%P/E Ratio13.2310.0930.1428.91Price / Sales0.691.44435.1251.05Price / Cash9.498.7625.7818.23Price / Book2.862.399.424.69Net Income$14.41B$2.64B$3.27B$995.89M7 Day Performance0.49%4.06%3.64%2.23%1 Month Performance8.75%4.17%3.52%2.46%1 Year Performance-48.01%-36.33%29.94%10.46% UnitedHealth Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UNHUnitedHealth Group4.9645 of 5 stars$305.26-0.7%$365.38+19.7%-47.8%$278.42B$400.28B13.23400,000Trending NewsAnalyst RevisionALKSAlkermes4.657 of 5 stars$28.30-1.1%$41.08+45.2%+3.8%$4.67B$1.51B13.611,800MEDPMedpace4.3131 of 5 stars$459.13-1.9%$406.60-11.4%+19.4%$12.90B$2.11B34.145,900Positive NewsCICigna Group5 of 5 stars$290.55+1.2%$378.33+30.2%-15.0%$77.56B$247.12B15.8673,500Positive NewsCNCCentene4.861 of 5 stars$26.93-0.5%$42.20+56.7%-63.0%$13.23B$178.19B6.6760,500Trending NewsCVSCVS Health4.9668 of 5 stars$66.77+1.3%$76.00+13.8%+21.2%$84.68B$386.64B18.65300,000Positive NewsELVElevance Health4.8769 of 5 stars$295.35+0.3%$418.19+41.6%-42.4%$66.51B$177.01B12.57104,200Positive NewsHCAHCA Healthcare4.6792 of 5 stars$393.86+0.9%$398.58+1.2%+3.7%$92.16B$70.60B16.56316,000Positive NewsHUMHumana4.1726 of 5 stars$282.03+0.0%$281.45-0.2%-15.6%$33.92B$117.76B21.6465,680Positive NewsDividend AnnouncementJNJJohnson & Johnson4.8708 of 5 stars$174.96+0.3%$174.50-0.3%+8.8%$421.37B$88.82B18.71138,100Trending NewsOptions VolumeMOHMolina Healthcare4.9433 of 5 stars$159.70-0.9%$244.55+53.1%-49.3%$8.66B$43.41B7.8718,000Positive News Related Companies and Tools Related Companies Alkermes Alternatives Medpace Alternatives Cigna Group Alternatives Centene Alternatives CVS Health Alternatives Elevance Health Alternatives HCA Healthcare Alternatives Humana Alternatives Johnson & Johnson Alternatives Molina Healthcare Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UNH) was last updated on 8/26/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UnitedHealth Group Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share UnitedHealth Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access